Amicus Therapeutics, Inc
FOLD Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Income
Balance Sheet
Cash Flow
FOLD Income Statement
FOLD Balance Sheet
FOLD Cash Flow
Recent trades of FOLD by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Daniel S. Goldman House / D | Sale $1,001 - $15,000 | Apr. 10, 2023 |
FOLD Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
FOLD Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
FOLD Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by FOLD's directors and management
Government lobbying spending instances
-
$10,000 Oct 10, 2024 Issue: Health Issues
-
$10,000 Jul 02, 2024 Issue: Health Issues
-
$10,000 Apr 01, 2024 Issue: Health Issues
-
$10,000 Oct 05, 2023 Issue: Health Issues
-
$20,000 Jul 21, 2023 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
-
$10,000 Jun 30, 2023 Issue: Health Issues
-
$20,000 Apr 20, 2023 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
-
$10,000 Apr 05, 2023 Issue: Health Issues
-
$20,000 Jan 23, 2023 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
-
$10,000 Jan 01, 2023 Issue: Health Issues
-
$20,000 Oct 24, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
-
$10,000 Oct 04, 2022 Issue: Health Issues
-
$20,000 Jul 27, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
-
$10,000 Jul 05, 2022 Issue: Health Issues
-
$20,000 Apr 20, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
-
$10,000 Apr 04, 2022 Issue: Health Issues
-
$20,000 Jan 30, 2022 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs
-
$10,000 Jan 04, 2022 Issue: Health Issues
-
$20,000 Oct 27, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$10,000 Oct 01, 2021 Issue: Health Issues
-
$20,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$10,000 Jul 06, 2021 Issue: Health Issues
-
$20,000 Apr 22, 2021 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
-
$10,000 Apr 15, 2021 Issue: Health Issues
-
$10,000 Jan 05, 2021 Issue: Health Issues
-
$10,000 Oct 02, 2020 Issue: Health Issues
-
$10,000 Jul 16, 2020 Issue: Health Issues
-
$10,000 Apr 11, 2020 Issue: Health Issues
-
$10,000 Jan 13, 2020 Issue: Health Issues
-
$20,000 Jan 10, 2020 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid
-
$20,000 Oct 18, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
-
$10,000 Oct 15, 2019 Issue: Health Issues
-
$10,000 Jul 05, 2019 Issue: Health Issues
-
$10,000 Apr 17, 2019 Issue: Health Issues
-
$10,000 Jan 16, 2019 Issue: Health Issues
-
$10,000 Oct 15, 2018 Issue: Health Issues
-
$10,000 Jul 18, 2018 Issue: Health Issues
-
$10,000 Apr 10, 2018 Issue: Health Issues
-
$10,000 Jan 19, 2018 Issue: Health Issues
-
$10,000 Oct 20, 2017 Issue: Health Issues
-
$10,000 Jul 20, 2017 Issue: Health Issues
-
$10,000 Apr 21, 2017 Issue: Health Issues
-
$10,000 Jan 20, 2017 Issue: Health Issues
-
$10,000 Oct 20, 2016 Issue: Health Issues
-
$10,000 Jul 20, 2016 Issue: Health Issues
-
$10,000 Apr 19, 2016 Issue: Health Issues
-
$10,000 Jan 20, 2016 Issue: Health Issues
-
$15,000 Oct 20, 2015 Issue: Health Issues
-
$15,000 Jul 20, 2015 Issue: Health Issues
-
$10,000 Oct 15, 2010 Issue: Health Issues
-
$20,000 Jul 16, 2010 Issue: Health Issues
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
- $21,089 2024-11-14 00:00:00 Agency: Department of Veterans Affairs
- $253,074 2024-11-13 00:00:00 Agency: Department of Veterans Affairs
- $63,268 2024-10-29 00:00:00 Agency: Department of Veterans Affairs
- $84,358 2024-10-29 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-10-24 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-10-15 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-10-03 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-09-23 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-09-23 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-08-29 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-08-23 00:00:00 Agency: Department of Veterans Affairs
- $0 2024-08-15 00:00:00 Agency: Department of Veterans Affairs
- $63,268 2024-08-02 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-07-25 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-07-24 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-07-18 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-07-02 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-06-06 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-06-04 00:00:00 Agency: Department of Veterans Affairs
- $63,268 2024-05-08 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-05-08 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-05-08 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-04-05 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-04-05 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-04-02 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-03-06 00:00:00 Agency: Department of Veterans Affairs
- $63,268 2024-03-05 00:00:00 Agency: Department of Veterans Affairs
- $147,626 2024-02-22 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-02-09 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-01-24 00:00:00 Agency: None
- $21,089 2024-01-24 00:00:00 Agency: Department of Veterans Affairs
- $21,089 2024-01-16 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-12-27 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-12-06 00:00:00 Agency: Department of Veterans Affairs
- $60,375 2023-11-13 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-11-08 00:00:00 Agency: Department of Veterans Affairs
- $120,749 2023-10-19 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-10-12 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-08-31 00:00:00 Agency: Department of Veterans Affairs
- $60,375 2023-08-23 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-08-05 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-07-07 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-06-12 00:00:00 Agency: Department of Veterans Affairs
- $60,375 2023-05-23 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-05-17 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-04-19 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-03-31 00:00:00 Agency: Department of Veterans Affairs
- $60,375 2023-03-10 00:00:00 Agency: Department of Veterans Affairs
- $20,125 2023-03-02 00:00:00 Agency: Department of Veterans Affairs
- $181,124 2023-02-07 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of FOLD in WallStreetBets Daily Discussion
FOLD News
Recent insights relating to FOLD
CNBC Recommendations
Recent picks made for FOLD stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in FOLD
FOLD Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view FOLD Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More